M&A deal
Merger and acquisition consolidation, common in many industries, has slowed for health care in 2024 due to multiple factors, writes Shawn Janus, national director of health care services for Colliers. The economics were strained as increased interest rates, the resulting capital costs, increased regulatory scrutiny, and a slower-than-expected pandemic recovery made large transactions harder to finance. However, a few fundamental factors will likely drive M&A activity in the sector through 2025.
Health care M&A deal volume dropped 20% between 2023 and 2024. Total deal values were down 29% year-over-year. Deal volume and value fell respectively by 18% and 31% in the pharmaceutical and life sciences sectors. Health care services saw year-over-year drops of 22% in volume and 21% in value.
Recommended For You
Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.
Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2025 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
